News

Find News

Filter articles

Showing 2431 to 2440 of 2651 results

US district court invalidates Megace patent

Taiwan, US25-02-2014Legal developments

The US District Court for the District of Maryland has ruled that Taiwanese company TWi Pharmaceuticals’ generic version of Par Pharmaceuticals’ Megace ES drug does not infringe US patent 7,101,576.

Bayer set to complete Algeta acquisition

Germany, Norway, US24-02-2014Mergers & acquisitions

Bayer will acquire Norwegian pharmaceutical company Algeta for €2.1 billion ($2.9 million), it announced on Monday.

Actavis to buy Forest for $25 billion

Ireland, US21-02-2014Mergers & acquisitions

Actavis has announced another expansion with the $25 billion acquisition of US pharmaceutical company Forest Laboratories.

Pfizer Australia faces antitrust accusations

Australia18-02-2014

Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies.

Novartis boosts cancer immunotherapy research with CoStim acquisition

US18-02-2014Mergers & acquisitions

Novartis has announced it will acquire biotechnology company CoStim for an undisclosed sum.

Baker & McKenzie adds to IP team

UK17-02-2014

Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office.

MSF criticises US pressure on Indian patent policy

India, US17-02-2014

Humanitarian organisation Médecins Sans Frontières has criticised the US for pressuring the Indian government to review its patent policies.

Myriad and Gene by Gene settle BRCA litigation

US13-02-2014Legal developments

Myriad and its rival genetic diagnostics company Gene by Gene have agreed to settle their patent infringement case related to BRCA tests.

US Chamber of Commerce slams Indian patent practices

India, US12-02-2014

The US Chamber of Commerce has criticised India’s “recent pattern of pharma patent denials”, which it says “are not about access to medicine”.

Merck and Samsung Bioepis agree diabetes deal

South Korea, US11-02-2014

Pharmaceutical company Merck and Samsung Bioepis, a joint venture between South Korean firm Samsung and Biogen, have agreed to work on a diabetes treatment.

Showing 2431 to 2440 of 2651 results

LSIPR